<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p30" style="overflow: hidden; position: relative; background-color: white; width: 935px; height: 1210px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_30{left:119px;bottom:1134px;letter-spacing:0.11px;word-spacing:0.02px;}
#t2_30{left:808px;bottom:1132px;letter-spacing:-0.08px;}
#t3_30{left:162px;bottom:1085px;letter-spacing:0.1px;word-spacing:-0.65px;}
#t4_30{left:162px;bottom:1067px;letter-spacing:0.11px;word-spacing:1.4px;}
#t5_30{left:162px;bottom:1050px;letter-spacing:0.12px;word-spacing:6.73px;}
#t6_30{left:162px;bottom:1032px;letter-spacing:0.11px;word-spacing:1.94px;}
#t7_30{left:162px;bottom:1015px;letter-spacing:0.11px;word-spacing:0.02px;}
#t8_30{left:141px;bottom:958px;letter-spacing:0.15px;word-spacing:4.05px;}
#t9_30{left:162px;bottom:937px;letter-spacing:0.14px;}
#ta_30{left:162px;bottom:899px;letter-spacing:0.13px;word-spacing:0.03px;}
#tb_30{left:305px;bottom:899px;letter-spacing:0.11px;word-spacing:0.03px;}
#tc_30{left:162px;bottom:881px;letter-spacing:0.12px;word-spacing:2.04px;}
#td_30{left:162px;bottom:864px;letter-spacing:0.1px;word-spacing:0.02px;}
#te_30{left:162px;bottom:828px;letter-spacing:0.14px;}
#tf_30{left:253px;bottom:828px;letter-spacing:0.11px;word-spacing:0.74px;}
#tg_30{left:162px;bottom:811px;letter-spacing:0.11px;word-spacing:0.68px;}
#th_30{left:162px;bottom:793px;letter-spacing:0.11px;word-spacing:1.02px;}
#ti_30{left:162px;bottom:776px;letter-spacing:0.1px;word-spacing:0.02px;}
#tj_30{left:162px;bottom:758px;letter-spacing:0.13px;word-spacing:0.7px;}
#tk_30{left:319px;bottom:758px;letter-spacing:0.11px;word-spacing:0.7px;}
#tl_30{left:162px;bottom:740px;letter-spacing:0.11px;word-spacing:0.55px;}
#tm_30{left:162px;bottom:723px;letter-spacing:0.11px;word-spacing:0.03px;}
#tn_30{left:162px;bottom:706px;letter-spacing:0.12px;}
#to_30{left:220px;bottom:706px;letter-spacing:0.12px;word-spacing:1.37px;}
#tp_30{left:162px;bottom:688px;letter-spacing:0.12px;word-spacing:2.6px;}
#tq_30{left:162px;bottom:670px;letter-spacing:0.1px;word-spacing:-0.7px;}
#tr_30{left:162px;bottom:653px;letter-spacing:0.11px;word-spacing:0.63px;}
#ts_30{left:162px;bottom:635px;letter-spacing:0.11px;word-spacing:0.66px;}
#tt_30{left:162px;bottom:618px;letter-spacing:0.09px;word-spacing:-0.38px;}
#tu_30{left:365px;bottom:618px;letter-spacing:0.12px;word-spacing:-0.37px;}
#tv_30{left:162px;bottom:600px;letter-spacing:0.11px;word-spacing:0.2px;}
#tw_30{left:162px;bottom:582px;letter-spacing:0.1px;word-spacing:0.02px;}
#tx_30{left:162px;bottom:565px;letter-spacing:0.12px;word-spacing:0.99px;}
#ty_30{left:348px;bottom:565px;letter-spacing:0.11px;word-spacing:0.99px;}
#tz_30{left:162px;bottom:547px;letter-spacing:0.12px;word-spacing:3.06px;}
#t10_30{left:162px;bottom:530px;letter-spacing:0.11px;word-spacing:0.03px;}
#t11_30{left:141px;bottom:473px;letter-spacing:0.15px;}
#t12_30{left:162px;bottom:452px;letter-spacing:0.13px;word-spacing:0.01px;}
#t13_30{left:162px;bottom:414px;letter-spacing:0.13px;word-spacing:0.04px;}
#t14_30{left:282px;bottom:422px;}
#t15_30{left:287px;bottom:414px;}
#t16_30{left:294px;bottom:414px;letter-spacing:0.12px;word-spacing:0.02px;}
#t17_30{left:412px;bottom:422px;}
#t18_30{left:417px;bottom:414px;letter-spacing:0.11px;word-spacing:0.03px;}
#t19_30{left:788px;bottom:422px;}
#t1a_30{left:162px;bottom:404px;}
#t1b_30{left:170px;bottom:396px;letter-spacing:0.11px;word-spacing:0.98px;}
#t1c_30{left:725px;bottom:404px;}
#t1d_30{left:733px;bottom:396px;letter-spacing:0.11px;word-spacing:0.99px;}
#t1e_30{left:162px;bottom:378px;letter-spacing:0.11px;word-spacing:-0.84px;}
#t1f_30{left:162px;bottom:361px;letter-spacing:0.09px;word-spacing:0.03px;}
#t1g_30{left:162px;bottom:326px;letter-spacing:0.11px;word-spacing:1.03px;}
#t1h_30{left:162px;bottom:308px;letter-spacing:0.11px;word-spacing:0.25px;}
#t1i_30{left:162px;bottom:291px;letter-spacing:0.11px;word-spacing:0.33px;}
#t1j_30{left:162px;bottom:273px;letter-spacing:0.11px;word-spacing:0.75px;}
#t1k_30{left:162px;bottom:256px;letter-spacing:0.1px;word-spacing:0.85px;}
#t1l_30{left:162px;bottom:238px;letter-spacing:0.11px;word-spacing:-0.07px;}
#t1m_30{left:162px;bottom:220px;letter-spacing:0.11px;word-spacing:0.67px;}
#t1n_30{left:162px;bottom:203px;letter-spacing:0.12px;word-spacing:0.87px;}
#t1o_30{left:162px;bottom:185px;letter-spacing:0.12px;word-spacing:2.96px;}
#t1p_30{left:162px;bottom:168px;letter-spacing:0.1px;word-spacing:-0.62px;}
#t1q_30{left:162px;bottom:150px;letter-spacing:0.12px;word-spacing:5.57px;}
#t1r_30{left:162px;bottom:133px;letter-spacing:0.12px;word-spacing:4.19px;}
#t1s_30{left:162px;bottom:115px;letter-spacing:0.1px;word-spacing:-0.26px;}
#t1t_30{left:162px;bottom:98px;letter-spacing:0.11px;word-spacing:0.05px;}
#t1u_30{left:162px;bottom:80px;letter-spacing:0.11px;word-spacing:0.48px;}

.s0_30{font-size:15px;font-family:TimesNewRomanPSMT_6e;color:#000;}
.s1_30{font-size:17px;font-family:Calibri_7k;color:#000;}
.s2_30{font-size:18px;font-family:TimesNewRomanPS-BoldMT_7w;color:#000;}
.s3_30{font-size:15px;font-family:TimesNewRomanPS-BoldMT_7s;color:#000;}
.s4_30{font-size:10px;font-family:TimesNewRomanPS-BoldMT_8j;color:#000;}
.s5_30{font-size:10px;font-family:TimesNewRomanPSMT_87;color:#000;}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts30" type="text/css" >

@font-face {
	font-family: Calibri_7k;
	src: url("fonts/Calibri_7k.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPS-BoldMT_7s;
	src: url("fonts/TimesNewRomanPS-BoldMT_7s.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPS-BoldMT_7w;
	src: url("fonts/TimesNewRomanPS-BoldMT_7w.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPS-BoldMT_8j;
	src: url("fonts/TimesNewRomanPS-BoldMT_8j.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPSMT_6e;
	src: url("fonts/TimesNewRomanPSMT_6e.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPSMT_87;
	src: url("fonts/TimesNewRomanPSMT_87.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg30Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg30" style="-webkit-user-select: none;"><object width="935" height="1210" data="30/30.svg" type="image/svg+xml" id="pdf30" style="width:935px; height:1210px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_30" class="t s0_30">Brain: Chemistry to Cognition </span><span id="t2_30" class="t s1_30">22 </span>
<span id="t3_30" class="t s0_30">autophagic clearance pathways, contributing to their survival. Our results also indicated that pharmacological </span>
<span id="t4_30" class="t s0_30">agents targeting specific mitochondrial pathways (alone or in combination with GBM therapeutics) could </span>
<span id="t5_30" class="t s0_30">effectively sensitize GICs population and inhibit their growth potential. Altogether, alteration in </span>
<span id="t6_30" class="t s0_30">mitochondrial pathways contributes to GICS survival and therapeutic targeting of specific mitochondrial </span>
<span id="t7_30" class="t s0_30">quality control pathway could be useful to combine with existing therapeutics for effective GBM treatment. </span>
<span id="t8_30" class="t s2_30">S8.2. Critical role of mitochondrial metabolism in drug resistance of Glioblastoma </span>
<span id="t9_30" class="t s2_30">Multiforme. </span>
<span id="ta_30" class="t s3_30">Ashutosh Shrivastava</span><span id="tb_30" class="t s0_30">, Manendra Singh Tomar </span>
<span id="tc_30" class="t s0_30">Center for Advance Research, Faculty of Medicine, King George’s Medical University, Lucknow, Uttar </span>
<span id="td_30" class="t s0_30">Pradesh, India </span>
<span id="te_30" class="t s3_30">Background: </span><span id="tf_30" class="t s0_30">Glioblastoma Multiforme (GBM) is the primary brain neoplasm with a low median survival </span>
<span id="tg_30" class="t s0_30">of ~15 months after the initial diagnosis.  Temozolomide (TMZ) is a first-choice alkylating agent inducted </span>
<span id="th_30" class="t s0_30">as a standard therapy for GBM. However, efficacy of TMZ is limited due to development of intrinsic and </span>
<span id="ti_30" class="t s0_30">extrinsic drug resistance. </span>
<span id="tj_30" class="t s3_30">Material and Methods: </span><span id="tk_30" class="t s0_30">We established a model of acquired TMZ-resistance in GBM. We performed cell </span>
<span id="tl_30" class="t s0_30">cytotoxicity assay to find out IC-50 of sensitive and resistant U-87 and LN-229 GBM cells. We used Gene </span>
<span id="tm_30" class="t s0_30">expression. Flow cytometry and Metabolomics to understand the mechanism of TMZ resistance in GBM. </span>
<span id="tn_30" class="t s3_30">Results: </span><span id="to_30" class="t s0_30">The IC-50 of sensitive U-87MG and LN-229 was ~60µM and ~10µM respectively compared to </span>
<span id="tp_30" class="t s0_30">365.5µM of U-87MG and 135.3 for the LN-229 resistant cells. The mitochondrial copy numbers were </span>
<span id="tq_30" class="t s0_30">significantly decreased while membrane potential was significantly higher in the resistant cell lines compared </span>
<span id="tr_30" class="t s0_30">to sensitive cells. There was a decrease in the expression of TFAM and PGC –α gene in the resistant cells. </span>
<span id="ts_30" class="t s0_30">We also found elevated level of ROS in sensitive cell lines on TMZ treatment but no significant change in </span>
<span id="tt_30" class="t s0_30">ROS levels in the resistant cells. </span><span id="tu_30" class="t s0_30">We subsequently performed Metabolomics and found TCA cycle, Warburg </span>
<span id="tv_30" class="t s0_30">effect, Pentose Phosphate Pathway, glutathione metabolism and nucleotide metabolism to be upregulated in </span>
<span id="tw_30" class="t s0_30">the resistant GBM. </span>
<span id="tx_30" class="t s3_30">Discussion and Conclusion: </span><span id="ty_30" class="t s0_30">Based on these preliminary findings, it can be concluded that TMZ resistant </span>
<span id="tz_30" class="t s0_30">cell lines have decreased mitochondrial DNA number. On the other hand upregulated TCA cycle and </span>
<span id="t10_30" class="t s0_30">Warburg effect for energy production provide these cells with survival advantage. </span>
<span id="t11_30" class="t s2_30">S8.3. Exploring the role of autophagy in temozolomide-induced glioma cancer stem </span>
<span id="t12_30" class="t s2_30">cells population </span>
<span id="t13_30" class="t s3_30">Meenakshi Tiwari </span>
<span id="t14_30" class="t s4_30">a </span>
<span id="t15_30" class="t s3_30">, </span><span id="t16_30" class="t s0_30">Suraj Kumar Singh </span>
<span id="t17_30" class="t s5_30">a </span>
<span id="t18_30" class="t s0_30">, Sabiya Abbas, Pransu Srivastava, Lokendra Kumar Sharma </span>
<span id="t19_30" class="t s5_30">b </span>
<span id="t1a_30" class="t s5_30">a </span>
<span id="t1b_30" class="t s0_30">Department of Biochemistry, All India Institute of Medical Sciences-Patna, Bihar, India; </span>
<span id="t1c_30" class="t s5_30">b </span>
<span id="t1d_30" class="t s0_30">Department of </span>
<span id="t1e_30" class="t s0_30">Molecular Medicine &amp; Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences-Lucknow, </span>
<span id="t1f_30" class="t s0_30">(U.P.) India. </span>
<span id="t1g_30" class="t s0_30">Glioblastomas (GBM) are highly recurrent and aggressive tumors that are associated with poor prognosis. </span>
<span id="t1h_30" class="t s0_30">The existence of glioma stem cell (GSC) populations has been identified in these tumors that are associated </span>
<span id="t1i_30" class="t s0_30">with aggressiveness and recurrence of the tumors. These GSCs possess properties of stem cells that include </span>
<span id="t1j_30" class="t s0_30">self-renewability, proliferation, and therapeutic resistance, contributing to the poor clinical outcome. Thus, </span>
<span id="t1k_30" class="t s0_30">targeting these stem cells in tumors offers a reliable and potential target to improve treatment outcomes in </span>
<span id="t1l_30" class="t s0_30">glioblastoma. Our laboratory focuses on understanding the role of autophagy in the existence of cancer stem </span>
<span id="t1m_30" class="t s0_30">cells (CSCs) in tumors, specifically in high grade gliomas. We have identified the role of autophagy in the </span>
<span id="t1n_30" class="t s0_30">maintenance of GSCs as well as Temozolomide (TMZ)-induced therapeutic response, the most commonly </span>
<span id="t1o_30" class="t s0_30">used treatment against GBM. Using primary and well-established cell lines of human origin, we have </span>
<span id="t1p_30" class="t s0_30">demonstrated the role of autophagy in maintaining the glioma stem cell population. Further, our experimental </span>
<span id="t1q_30" class="t s0_30">data suggested that autophagy provides a survival advantage to glioblastoma cells in response to </span>
<span id="t1r_30" class="t s0_30">chemotherapy. More interestingly, we have identified that TMZ treatment significantly increases the </span>
<span id="t1s_30" class="t s0_30">population of GSCs that is associated with upregulation of autophagy. Our findings implicate that, inhibition </span>
<span id="t1t_30" class="t s0_30">of autophagy prevented TMZ-induced increased GSC population, suggesting a critical role for autophagy in </span>
<span id="t1u_30" class="t s0_30">therapy-induced generation of the GSC pool. Currently, we are generating some exciting data that suggests </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
